Global Drug Discovery Biosimulation Software Market Research Report 2025

Drug Discovery Biosimulation Software Market

Drug discovery biosimulation software refers to a professional software tool that uses computer modeling, mathematical algorithms, and bioinformatics techniques to simulate and predict the interactions between drug molecules and biological systems (such as proteins, cells, tissues, or the entire organism). This type of software can predict the pharmacological activity, toxicity, and pharmacokinetic properties of candidate compounds in a virtual environment by establishing quantitative structure-activity relationships (QSAR), molecular dynamics simulations, systems biology models, and other methods, thereby significantly reducing the laboratory testing and animal experiments required in traditional drug discovery processes.

The global market for biosimulation software for drug discovery has shown a steady growth trend in recent years. Biological simulation technology can help pharmaceutical companies reduce research and development costs and shorten research and development cycles. The cost-benefit ratio is particularly important in the context of patent cliff and medical expenditure control. Regulatory agencies such as the US FDA and European EMA are increasingly accepting modeling and simulation data as auxiliary evidence for new drug applications. The integration of artificial intelligence algorithms, high-performance computing, and biological big data analysis has significantly improved the predictive accuracy and applicability of biological simulations, making them gradually become one of the core methods for drug discovery from auxiliary tools. The rise of precision medicine and personalized dosing regimens has increased the demand for patient specific simulations, driving the expansion of the application of biosimulation software in preclinical and clinical stages. North America currently holds the largest market share, followed by Europe and the Asia Pacific region. The market presents a diversified competitive pattern and moderate concentration characteristics. The main participants include well-known companies such as Biolauncher, Certara, Dassault Systemes, etc. Leading companies mainly maintain and expand their market position through technological innovation, strategic mergers and acquisitions, partnerships, and cloud service transformation. In the Chinese market, core technologies and high-end markets are still dominated by international giants, but local enterprises such as Tencent AI Lab and PharmaResources are gradually increasing their influence through independent research and development and strategic cooperation. In the future, the integration of artificial intelligence will become the most significant trend in technological development. The new generation of AI driven simulation tools can learn complex patterns from massive biomedical data and achieve higher precision predictions. The next generation of biological simulation software will have the ability to integrate and analyze multidimensional data such as genomics, proteomics, metabolomics, etc., and construct multi-scale models that are closer to real biological systems.

This report aims to provide a comprehensive presentation of the global market for Drug Discovery Biosimulation Software, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Discovery Biosimulation Software.

The Drug Discovery Biosimulation Software market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Discovery Biosimulation Software market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drug Discovery Biosimulation Software companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Drug Discovery Biosimulation Software Market Report

Chapter Outline

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drug Discovery Biosimulation Software Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Molecular Modeling And Structural Prediction Software

1.2.3 Virtual Screening And Molecular Design Software

1.2.4 ADMET Prediction Software

1.2.5 Molecular Dynamics Simulation Software

1.2.6 Systems Biology And Multiscale Modeling Software

1.2.7 Others

1.3 Market by Application

1.3.1 Global Drug Discovery Biosimulation Software Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Target Recognition

1.3.3 Virtual Screening

1.3.4 Lead Optimization

1.3.5 Pharmacokinetic Simulation

1.3.6 Toxic Predicting

1.3.7 Mechanism Analysis

1.3.8 Effect Analysis

1.3.9 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2.1 Global Drug Discovery Biosimulation Software Market Perspective (2020-2031)

2.2 Global Drug Discovery Biosimulation Software Growth Trends by Region

2.2.1 Global Drug Discovery Biosimulation Software Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Drug Discovery Biosimulation Software Historic Market Size by Region (2020-2025)

2.2.3 Drug Discovery Biosimulation Software Forecasted Market Size by Region (2026-2031)

2.3 Drug Discovery Biosimulation Software Market Dynamics

2.3.1 Drug Discovery Biosimulation Software Industry Trends

2.3.2 Drug Discovery Biosimulation Software Market Drivers

2.3.3 Drug Discovery Biosimulation Software Market Challenges

2.3.4 Drug Discovery Biosimulation Software Market Restraints

3.1 Global Top Drug Discovery Biosimulation Software Players by Revenue

3.1.1 Global Top Drug Discovery Biosimulation Software Players by Revenue (2020-2025)

3.1.2 Global Drug Discovery Biosimulation Software Revenue Market Share by Players (2020-2025)

3.2 Global Top Drug Discovery Biosimulation Software Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Drug Discovery Biosimulation Software Revenue

3.4 Global Drug Discovery Biosimulation Software Market Concentration Ratio

3.4.1 Global Drug Discovery Biosimulation Software Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drug Discovery Biosimulation Software Revenue in 2024

3.5 Global Key Players of Drug Discovery Biosimulation Software Head office and Area Served

3.6 Global Key Players of Drug Discovery Biosimulation Software, Product and Application

3.7 Global Key Players of Drug Discovery Biosimulation Software, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Drug Discovery Biosimulation Software Historic Market Size by Type (2020-2025)

4.2 Global Drug Discovery Biosimulation Software Forecasted Market Size by Type (2026-2031)

5.1 Global Drug Discovery Biosimulation Software Historic Market Size by Application (2020-2025)

5.2 Global Drug Discovery Biosimulation Software Forecasted Market Size by Application (2026-2031)

6.1 North America Drug Discovery Biosimulation Software Market Size (2020-2031)

6.2 North America Drug Discovery Biosimulation Software Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Drug Discovery Biosimulation Software Market Size by Country (2020-2025)

6.4 North America Drug Discovery Biosimulation Software Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7.1 Europe Drug Discovery Biosimulation Software Market Size (2020-2031)

7.2 Europe Drug Discovery Biosimulation Software Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Drug Discovery Biosimulation Software Market Size by Country (2020-2025)

7.4 Europe Drug Discovery Biosimulation Software Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Drug Discovery Biosimulation Software Market Size (2020-2031)

8.2 Asia-Pacific Drug Discovery Biosimulation Software Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Drug Discovery Biosimulation Software Market Size by Region (2020-2025)

8.4 Asia-Pacific Drug Discovery Biosimulation Software Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Drug Discovery Biosimulation Software Market Size (2020-2031)

9.2 Latin America Drug Discovery Biosimulation Software Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Drug Discovery Biosimulation Software Market Size by Country (2020-2025)

9.4 Latin America Drug Discovery Biosimulation Software Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Drug Discovery Biosimulation Software Market Size (2020-2031)

10.2 Middle East & Africa Drug Discovery Biosimulation Software Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Drug Discovery Biosimulation Software Market Size by Country (2020-2025)

10.4 Middle East & Africa Drug Discovery Biosimulation Software Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Biolauncher

11.1.1 Biolauncher Company Details

11.1.2 Biolauncher Business Overview

11.1.3 Biolauncher Drug Discovery Biosimulation Software Introduction

11.1.4 Biolauncher Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.1.5 Biolauncher Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Drug Discovery Biosimulation Software Introduction

11.2.4 Pfizer Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.2.5 Pfizer Recent Development

11.3 Dassault Systemes

11.3.1 Dassault Systemes Company Details

11.3.2 Dassault Systemes Business Overview

11.3.3 Dassault Systemes Drug Discovery Biosimulation Software Introduction

11.3.4 Dassault Systemes Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.3.5 Dassault Systemes Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Drug Discovery Biosimulation Software Introduction

11.4.4 Novartis Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.4.5 Novartis Recent Development

11.5 Schrodinger

11.5.1 Schrodinger Company Details

11.5.2 Schrodinger Business Overview

11.5.3 Schrodinger Drug Discovery Biosimulation Software Introduction

11.5.4 Schrodinger Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.5.5 Schrodinger Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Drug Discovery Biosimulation Software Introduction

11.6.4 AstraZeneca Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.6.5 AstraZeneca Recent Development

11.7 Insilico Medicine

11.7.1 Insilico Medicine Company Details

11.7.2 Insilico Medicine Business Overview

11.7.3 Insilico Medicine Drug Discovery Biosimulation Software Introduction

11.7.4 Insilico Medicine Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.7.5 Insilico Medicine Recent Development

11.8 Simulations Plus

11.8.1 Simulations Plus Company Details

11.8.2 Simulations Plus Business Overview

11.8.3 Simulations Plus Drug Discovery Biosimulation Software Introduction

11.8.4 Simulations Plus Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.8.5 Simulations Plus Recent Development

11.9 Molecular Networks

11.9.1 Molecular Networks Company Details

11.9.2 Molecular Networks Business Overview

11.9.3 Molecular Networks Drug Discovery Biosimulation Software Introduction

11.9.4 Molecular Networks Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.9.5 Molecular Networks Recent Development

11.10 Evotec

11.10.1 Evotec Company Details

11.10.2 Evotec Business Overview

11.10.3 Evotec Drug Discovery Biosimulation Software Introduction

11.10.4 Evotec Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.10.5 Evotec Recent Development

11.11 Boehringer Ingelheim

11.11.1 Boehringer Ingelheim Company Details

11.11.2 Boehringer Ingelheim Business Overview

11.11.3 Boehringer Ingelheim Drug Discovery Biosimulation Software Introduction

11.11.4 Boehringer Ingelheim Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.11.5 Boehringer Ingelheim Recent Development

11.12 Certara

11.12.1 Certara Company Details

11.12.2 Certara Business Overview

11.12.3 Certara Drug Discovery Biosimulation Software Introduction

11.12.4 Certara Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.12.5 Certara Recent Development

11.13 Tencent AI Lab

11.13.1 Tencent AI Lab Company Details

11.13.2 Tencent AI Lab Business Overview

11.13.3 Tencent AI Lab Drug Discovery Biosimulation Software Introduction

11.13.4 Tencent AI Lab Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.13.5 Tencent AI Lab Recent Development

11.14 PharmaResources

11.14.1 PharmaResources Company Details

11.14.2 PharmaResources Business Overview

11.14.3 PharmaResources Drug Discovery Biosimulation Software Introduction

11.14.4 PharmaResources Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.14.5 PharmaResources Recent Development

11.15 Quantum Hi-Tech (China) Biotechnology

11.15.1 Quantum Hi-Tech (China) Biotechnology Company Details

11.15.2 Quantum Hi-Tech (China) Biotechnology Business Overview

11.15.3 Quantum Hi-Tech (China) Biotechnology Drug Discovery Biosimulation Software Introduction

11.15.4 Quantum Hi-Tech (China) Biotechnology Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.15.5 Quantum Hi-Tech (China) Biotechnology Recent Development

11.16 Leto Laboratories

11.16.1 Leto Laboratories Company Details

11.16.2 Leto Laboratories Business Overview

11.16.3 Leto Laboratories Drug Discovery Biosimulation Software Introduction

11.16.4 Leto Laboratories Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.16.5 Leto Laboratories Recent Development

11.17 Zuoshouyisheng

11.17.1 Zuoshouyisheng Company Details

11.17.2 Zuoshouyisheng Business Overview

11.17.3 Zuoshouyisheng Drug Discovery Biosimulation Software Introduction

11.17.4 Zuoshouyisheng Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.17.5 Zuoshouyisheng Recent Development

11.18 Taimei Technology

11.18.1 Taimei Technology Company Details

11.18.2 Taimei Technology Business Overview

11.18.3 Taimei Technology Drug Discovery Biosimulation Software Introduction

11.18.4 Taimei Technology Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.18.5 Taimei Technology Recent Development

11.19 AIxplorerbio

11.19.1 AIxplorerbio Company Details

11.19.2 AIxplorerbio Business Overview

11.19.3 AIxplorerbio Drug Discovery Biosimulation Software Introduction

11.19.4 AIxplorerbio Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.19.5 AIxplorerbio Recent Development

11.20 Moore Threads

11.20.1 Moore Threads Company Details

11.20.2 Moore Threads Business Overview

11.20.3 Moore Threads Drug Discovery Biosimulation Software Introduction

11.20.4 Moore Threads Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.20.5 Moore Threads Recent Development

11.21 StoneWise

11.21.1 StoneWise Company Details

11.21.2 StoneWise Business Overview

11.21.3 StoneWise Drug Discovery Biosimulation Software Introduction

11.21.4 StoneWise Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.21.5 StoneWise Recent Development

11.22 NovaX Biotech

11.22.1 NovaX Biotech Company Details

11.22.2 NovaX Biotech Business Overview

11.22.3 NovaX Biotech Drug Discovery Biosimulation Software Introduction

11.22.4 NovaX Biotech Revenue in Drug Discovery Biosimulation Software Business (2020-2025)

11.22.5 NovaX Biotech Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

 Table 1. Global Drug Discovery Biosimulation Software Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

 Table 2. Key Players of Molecular Modeling And Structural Prediction Software

 Table 3. Key Players of Virtual Screening And Molecular Design Software

 Table 4. Key Players of ADMET Prediction Software

 Table 5. Key Players of Molecular Dynamics Simulation Software

 Table 6. Key Players of Systems Biology And Multiscale Modeling Software

 Table 7. Key Players of Others

 Table 8. Global Drug Discovery Biosimulation Software Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

 Table 9. Global Drug Discovery Biosimulation Software Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

 Table 10. Global Drug Discovery Biosimulation Software Market Size by Region (2020-2025) & (US$ Million)

 Table 11. Global Drug Discovery Biosimulation Software Market Share by Region (2020-2025)

 Table 12. Global Drug Discovery Biosimulation Software Forecasted Market Size by Region (2026-2031) & (US$ Million)

 Table 13. Global Drug Discovery Biosimulation Software Market Share by Region (2026-2031)

 Table 14. Drug Discovery Biosimulation Software Market Trends

 Table 15. Drug Discovery Biosimulation Software Market Drivers

 Table 16. Drug Discovery Biosimulation Software Market Challenges

 Table 17. Drug Discovery Biosimulation Software Market Restraints

 Table 18. Global Drug Discovery Biosimulation Software Revenue by Players (2020-2025) & (US$ Million)

 Table 19. Global Drug Discovery Biosimulation Software Market Share by Players (2020-2025)

 Table 20. Global Top Drug Discovery Biosimulation Software Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Discovery Biosimulation Software as of 2024)

 Table 21. Ranking of Global Top Drug Discovery Biosimulation Software Companies by Revenue (US$ Million) in 2024

 Table 22. Global 5 Largest Players Market Share by Drug Discovery Biosimulation Software Revenue (CR5 and HHI) & (2020-2025)

 Table 23. Global Key Players of Drug Discovery Biosimulation Software, Headquarters and Area Served

 Table 24. Global Key Players of Drug Discovery Biosimulation Software, Product and Application

 Table 25. Global Key Players of Drug Discovery Biosimulation Software, Date of Enter into This Industry

 Table 26. Mergers & Acquisitions, Expansion Plans

 Table 27. Global Drug Discovery Biosimulation Software Market Size by Type (2020-2025) & (US$ Million)

 Table 28. Global Drug Discovery Biosimulation Software Revenue Market Share by Type (2020-2025)

 Table 29. Global Drug Discovery Biosimulation Software Forecasted Market Size by Type (2026-2031) & (US$ Million)

 Table 30. Global Drug Discovery Biosimulation Software Revenue Market Share by Type (2026-2031)

 Table 31. Global Drug Discovery Biosimulation Software Market Size by Application (2020-2025) & (US$ Million)

 Table 32. Global Drug Discovery Biosimulation Software Revenue Market Share by Application (2020-2025)

 Table 33. Global Drug Discovery Biosimulation Software Forecasted Market Size by Application (2026-2031) & (US$ Million)

 Table 34. Global Drug Discovery Biosimulation Software Revenue Market Share by Application (2026-2031)

 Table 35. North America Drug Discovery Biosimulation Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

 Table 36. North America Drug Discovery Biosimulation Software Market Size by Country (2020-2025) & (US$ Million)

 Table 37. North America Drug Discovery Biosimulation Software Market Size by Country (2026-2031) & (US$ Million)

 Table 38. Europe Drug Discovery Biosimulation Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

 Table 39. Europe Drug Discovery Biosimulation Software Market Size by Country (2020-2025) & (US$ Million)

 Table 40. Europe Drug Discovery Biosimulation Software Market Size by Country (2026-2031) & (US$ Million)

 Table 41. Asia-Pacific Drug Discovery Biosimulation Software Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

 Table 42. Asia-Pacific Drug Discovery Biosimulation Software Market Size by Region (2020-2025) & (US$ Million)

 Table 43. Asia-Pacific Drug Discovery Biosimulation Software Market Size by Region (2026-2031) & (US$ Million)

 Table 44. Latin America Drug Discovery Biosimulation Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

 Table 45. Latin America Drug Discovery Biosimulation Software Market Size by Country (2020-2025) & (US$ Million)

 Table 46. Latin America Drug Discovery Biosimulation Software Market Size by Country (2026-2031) & (US$ Million)

 Table 47. Middle East & Africa Drug Discovery Biosimulation Software Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

 Table 48. Middle East & Africa Drug Discovery Biosimulation Software Market Size by Country (2020-2025) & (US$ Million)

 Table 49. Middle East & Africa Drug Discovery Biosimulation Software Market Size by Country (2026-2031) & (US$ Million)

 Table 50. Biolauncher Company Details

 Table 51. Biolauncher Business Overview

 Table 52. Biolauncher Drug Discovery Biosimulation Software Product

 Table 53. Biolauncher Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 54. Biolauncher Recent Development

 Table 55. Pfizer Company Details

 Table 56. Pfizer Business Overview

 Table 57. Pfizer Drug Discovery Biosimulation Software Product

 Table 58. Pfizer Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 59. Pfizer Recent Development

 Table 60. Dassault Systemes Company Details

 Table 61. Dassault Systemes Business Overview

 Table 62. Dassault Systemes Drug Discovery Biosimulation Software Product

 Table 63. Dassault Systemes Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 64. Dassault Systemes Recent Development

 Table 65. Novartis Company Details

 Table 66. Novartis Business Overview

 Table 67. Novartis Drug Discovery Biosimulation Software Product

 Table 68. Novartis Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 69. Novartis Recent Development

 Table 70. Schrodinger Company Details

 Table 71. Schrodinger Business Overview

 Table 72. Schrodinger Drug Discovery Biosimulation Software Product

 Table 73. Schrodinger Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 74. Schrodinger Recent Development

 Table 75. AstraZeneca Company Details

 Table 76. AstraZeneca Business Overview

 Table 77. AstraZeneca Drug Discovery Biosimulation Software Product

 Table 78. AstraZeneca Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 79. AstraZeneca Recent Development

 Table 80. Insilico Medicine Company Details

 Table 81. Insilico Medicine Business Overview

 Table 82. Insilico Medicine Drug Discovery Biosimulation Software Product

 Table 83. Insilico Medicine Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 84. Insilico Medicine Recent Development

 Table 85. Simulations Plus Company Details

 Table 86. Simulations Plus Business Overview

 Table 87. Simulations Plus Drug Discovery Biosimulation Software Product

 Table 88. Simulations Plus Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 89. Simulations Plus Recent Development

 Table 90. Molecular Networks Company Details

 Table 91. Molecular Networks Business Overview

 Table 92. Molecular Networks Drug Discovery Biosimulation Software Product

 Table 93. Molecular Networks Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 94. Molecular Networks Recent Development

 Table 95. Evotec Company Details

 Table 96. Evotec Business Overview

 Table 97. Evotec Drug Discovery Biosimulation Software Product

 Table 98. Evotec Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 99. Evotec Recent Development

 Table 100. Boehringer Ingelheim Company Details

 Table 101. Boehringer Ingelheim Business Overview

 Table 102. Boehringer Ingelheim Drug Discovery Biosimulation Software Product

 Table 103. Boehringer Ingelheim Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 104. Boehringer Ingelheim Recent Development

 Table 105. Certara Company Details

 Table 106. Certara Business Overview

 Table 107. Certara Drug Discovery Biosimulation Software Product

 Table 108. Certara Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 109. Certara Recent Development

 Table 110. Tencent AI Lab Company Details

 Table 111. Tencent AI Lab Business Overview

 Table 112. Tencent AI Lab Drug Discovery Biosimulation Software Product

 Table 113. Tencent AI Lab Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 114. Tencent AI Lab Recent Development

 Table 115. PharmaResources Company Details

 Table 116. PharmaResources Business Overview

 Table 117. PharmaResources Drug Discovery Biosimulation Software Product

 Table 118. PharmaResources Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 119. PharmaResources Recent Development

 Table 120. Quantum Hi-Tech (China) Biotechnology Company Details

 Table 121. Quantum Hi-Tech (China) Biotechnology Business Overview

 Table 122. Quantum Hi-Tech (China) Biotechnology Drug Discovery Biosimulation Software Product

 Table 123. Quantum Hi-Tech (China) Biotechnology Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 124. Quantum Hi-Tech (China) Biotechnology Recent Development

 Table 125. Leto Laboratories Company Details

 Table 126. Leto Laboratories Business Overview

 Table 127. Leto Laboratories Drug Discovery Biosimulation Software Product

 Table 128. Leto Laboratories Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 129. Leto Laboratories Recent Development

 Table 130. Zuoshouyisheng Company Details

 Table 131. Zuoshouyisheng Business Overview

 Table 132. Zuoshouyisheng Drug Discovery Biosimulation Software Product

 Table 133. Zuoshouyisheng Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 134. Zuoshouyisheng Recent Development

 Table 135. Taimei Technology Company Details

 Table 136. Taimei Technology Business Overview

 Table 137. Taimei Technology Drug Discovery Biosimulation Software Product

 Table 138. Taimei Technology Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 139. Taimei Technology Recent Development

 Table 140. AIxplorerbio Company Details

 Table 141. AIxplorerbio Business Overview

 Table 142. AIxplorerbio Drug Discovery Biosimulation Software Product

 Table 143. AIxplorerbio Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 144. AIxplorerbio Recent Development

 Table 145. Moore Threads Company Details

 Table 146. Moore Threads Business Overview

 Table 147. Moore Threads Drug Discovery Biosimulation Software Product

 Table 148. Moore Threads Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 149. Moore Threads Recent Development

 Table 150. StoneWise Company Details

 Table 151. StoneWise Business Overview

 Table 152. StoneWise Drug Discovery Biosimulation Software Product

 Table 153. StoneWise Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 154. StoneWise Recent Development

 Table 155. NovaX Biotech Company Details

 Table 156. NovaX Biotech Business Overview

 Table 157. NovaX Biotech Drug Discovery Biosimulation Software Product

 Table 158. NovaX Biotech Revenue in Drug Discovery Biosimulation Software Business (2020-2025) & (US$ Million)

 Table 159. NovaX Biotech Recent Development

 Table 160. Research Programs/Design for This Report

 Table 161. Key Data Information from Secondary Sources

 Table 162. Key Data Information from Primary Sources

 Table 163. Authors List of This Report

List of Figures

 Figure 1. Drug Discovery Biosimulation Software Picture

 Figure 2. Global Drug Discovery Biosimulation Software Market Size Comparison by Type (2020-2031) & (US$ Million)

 Figure 3. Global Drug Discovery Biosimulation Software Market Share by Type: 2024 VS 2031

 Figure 4. Molecular Modeling And Structural Prediction Software Features

 Figure 5. Virtual Screening And Molecular Design Software Features

 Figure 6. ADMET Prediction Software Features

 Figure 7. Molecular Dynamics Simulation Software Features

 Figure 8. Systems Biology And Multiscale Modeling Software Features

 Figure 9. Others Features

 Figure 10. Global Drug Discovery Biosimulation Software Market Size by Application (2020-2031) & (US$ Million)

 Figure 11. Global Drug Discovery Biosimulation Software Market Share by Application: 2024 VS 2031

 Figure 12. Target Recognition Case Studies

 Figure 13. Virtual Screening Case Studies

 Figure 14. Lead Optimization Case Studies

 Figure 15. Pharmacokinetic Simulation Case Studies

 Figure 16. Toxic Predicting Case Studies

 Figure 17. Mechanism Analysis Case Studies

 Figure 18. Effect Analysis Case Studies

 Figure 19. Others Case Studies

 Figure 20. Drug Discovery Biosimulation Software Report Years Considered

 Figure 21. Global Drug Discovery Biosimulation Software Market Size (US$ Million), Year-over-Year: 2020-2031

 Figure 22. Global Drug Discovery Biosimulation Software Market Size, (US$ Million), 2020 VS 2024 VS 2031

 Figure 23. Global Drug Discovery Biosimulation Software Market Share by Region: 2024 VS 2031

 Figure 24. Global Drug Discovery Biosimulation Software Market Share by Players in 2024

 Figure 25. Global Drug Discovery Biosimulation Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

 Figure 26. The Top 10 and 5 Players Market Share by Drug Discovery Biosimulation Software Revenue in 2024

 Figure 27. North America Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 28. North America Drug Discovery Biosimulation Software Market Share by Country (2020-2031)

 Figure 29. United States Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 30. Canada Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 31. Europe Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 32. Europe Drug Discovery Biosimulation Software Market Share by Country (2020-2031)

 Figure 33. Germany Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 34. France Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 35. U.K. Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 36. Italy Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 37. Russia Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 38. Nordic Countries Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 39. Asia-Pacific Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 40. Asia-Pacific Drug Discovery Biosimulation Software Market Share by Region (2020-2031)

 Figure 41. China Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 42. Japan Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 43. South Korea Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 44. Southeast Asia Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 45. India Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 46. Australia Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 47. Latin America Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 48. Latin America Drug Discovery Biosimulation Software Market Share by Country (2020-2031)

 Figure 49. Mexico Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 50. Brazil Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 51. Middle East & Africa Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 52. Middle East & Africa Drug Discovery Biosimulation Software Market Share by Country (2020-2031)

 Figure 53. Turkey Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 54. Saudi Arabia Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 55. UAE Drug Discovery Biosimulation Software Market Size YoY Growth (2020-2031) & (US$ Million)

 Figure 56. Biolauncher Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 57. Pfizer Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 58. Dassault Systemes Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 59. Novartis Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 60. Schrodinger Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 61. AstraZeneca Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 62. Insilico Medicine Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 63. Simulations Plus Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 64. Molecular Networks Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 65. Evotec Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 66. Boehringer Ingelheim Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 67. Certara Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 68. Tencent AI Lab Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 69. PharmaResources Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 70. Quantum Hi-Tech (China) Biotechnology Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 71. Leto Laboratories Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 72. Zuoshouyisheng Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 73. Taimei Technology Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 74. AIxplorerbio Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 75. Moore Threads Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 76. StoneWise Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 77. NovaX Biotech Revenue Growth Rate in Drug Discovery Biosimulation Software Business (2020-2025)

 Figure 78. Bottom-up and Top-down Approaches for This Report

 Figure 79. Data Triangulation

 Figure 80. Key Executives Interviewed